Advertisement

Probucol, a superoxide free radical scavenger in vitro

  • A.B. Bridges
    Correspondence
    Correspondence to: Dr. A.B. Bridges, Department of Medicine, Ninewells Hospital and Medical School, Dundee. DD1 9SY, Scotland, U.K. Tel.: (0382) 60111: Fax: (0382) 60675.
    Affiliations
    Departments of Medicine and Cardiology, Ninewells Hospital and Medical School, Dundee DDI 9SY, Scotland, U.K.
    Search for articles by this author
  • N.A. Scott
    Affiliations
    Departments of Medicine and Cardiology, Ninewells Hospital and Medical School, Dundee DDI 9SY, Scotland, U.K.
    Search for articles by this author
  • J.J.F. Belch
    Affiliations
    Departments of Medicine and Cardiology, Ninewells Hospital and Medical School, Dundee DDI 9SY, Scotland, U.K.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Free radical (FR) mediated oxidation of low density lipoproteins (LDL) has been implicated in atherogenesis. Probucol is a lipid lowering agent with antioxidant properties which may protect the LDL from FR mediated damage. The specific mechanism by which probucol acts as an antioxidant has not previously been reported. We therefore studied the FR scavenging properties of probucol in vitro and results show that this drug is a powerful superoxide scavenger. This property may be relevant in its use as a lipid lowering drug in the retardation of the atherosclerotic process.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Munro J.M.
        • Cotran R.S.
        The pathogenesis of atherosclerosis: atherogenesis and inflammation.
        Lab. Invest. 1988; 58: 249
        • Carew T.E.
        • Schwenke D.C.
        • Steinberg D.
        Antiatherogenic effect of probucol unrelated to its hypocholesterolaemic effect.
        in: Proc. Natl. Acad. Sci. USA. 84. 1987: 7725
        • Kita T.
        • Nagano Y.
        • Yokode M.
        • Ishii K.
        • Kume N.
        • Ooshima A.
        • Yoshida H.
        • Kawai C.
        Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit: an animal model for familial hypercholesterolemia.
        in: Proc. Natl. Acad. Sci. USA. 84. 1987: 5928
        • Misra H.P.
        • Fridovich L.
        Superoxide dismutase; a photochemical augmentation assay.
        Arch. Biochem., Biophys. 1977; 187: 303
        • Fellin R.
        • Gasparotto A.
        • Valerio G.
        • Baiocchi M.R.
        • Padrini R.
        • Lamon S.
        • Vitale E.
        • Baggio G.
        • Crepaldi G.
        Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolaemia.
        Atherosclerosis. 1986; 59: 47
        • Heeg J.
        • Tachizawa H.
        Plasma levels of probucol in man after single and repeated oral doses.
        Nouv. Presse Med. 1980; 9: 2990
        • Hessler J.R.
        • Robertson A.L.
        • Chisolm G.M.
        LDL induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cell in culture.
        Atherosclerosis. 1979; 32: 213
        • Quinn M.T.
        • Parthasarathy S.
        • Fong L.G.
        • Steinberg D.
        Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
        in: Proc. Natl. Acad. Sci. USA. 84. 1987: 2995
        • Quinn M.T.
        • Parthasarathy S.
        • Steinberg D.
        Endothelial cell derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein.
        in: Proc. Natl. Acad. Sci. USA. 82. 1985: 5949
        • Goldstein J.L.
        • Ho Y.K.
        • Basu S.K.
        • Brown M.S.
        Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.
        in: Proc. Natl. Acad. Sci. USA. 76. 1979: 333
        • Parthasarathy S.
        • Young S.G.
        • Witztum J.L.
        • Pittman R.C.
        • Steinberg D.
        Probucol inhibits oxidation modification of low density lipoproteins.
        J. Clin. Invest. 1986; 77: 641
        • Eder H.A.
        The effect of diet on the transport of probucol in monkeys.
        Artery. 1982; 10: 105